JC
Insider
James C Clemmer
President and CEOJames C Clemmer (President and CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in AngioDynamics, Inc. (ANGO). Across 1 priced purchase filing, the average 21-session return was +5.5% from execution and +5.5% from disclosure (delay-adjusted; derived). The largest single filing was $112K of ANGO (10,000 sh × $11.15, as filed), executed Oct 9 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+5.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+5.5%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$112K
shares × price, as filed
Last traded
Oct 9 2025
Filed Oct 9 2025
Median ADV $7.3M across their filed names
Open performance→Volume by month
Buys $232K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ANGORecent filings
ANGOPURCHASE
AngioDynamics, Inc.
View filing →
$112K10,000 sh × $11.15
Exec Oct 9 2025
Filed Oct 9 2025 · 9:09 PM ET ANGOPURCHASE AngioDynamics, Inc. View filing → $121K
20,000 sh × $6.03
Exec Oct 7 2024
Filed Oct 8 2024 · 5:30 PM ET